← All stocks

Quest Diagnostics

DGX Mostly scheduled
CIK 0001022079 #382 in the set updated 17 Sep 2026
Bought (120 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$483.21M
$23.42M on a plan · $441.66M straight out of an exercise
Sold at will
$18.13M
79 of 287 sales
Net
−$483.21M
−$18.13M against sales at will

By person

32 insiders · 287 transactions
23.7×

James E. Davis holds 23.7 times base salary in stock. $29.71M of shares against $1.25M in salary for 2025.

Salary from the company's own proxy. The shares are what James E. Davis last reported holding, valued at $242.72, the price Common Stock was last bought or sold at on the open market here, on 1 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
RUSCKOWSKI STEPHEN H
Director
$203.16M (33) scheduled
−$203.16M
389,597
0.3530%
$94.56M
+176.3%
PREVOZNIK MICHAEL E
SVP & General Counsel
$63.90M (55) scheduled
−$63.90M
42,337
0.0384%
$10.28M
−11.3%
Doherty Catherine T.
EVP, Regional Businesses
$60.76M (56) scheduled
−$60.76M
67,122
0.0608%
$16.29M
−12.5%
Davis J. E.
CEO and President
$51.69M (41) scheduled
−$51.69M
122,423
0.1109%
$29.71M
+284.6%
GUINAN MARK
Executive Vice President & CFO
$32.16M (8) scheduled
−$32.16M
98,981
0.0897%
$24.02M
+145.4%
Cohen Jon R
SVP & Group Exec. Diag. Sol.
$20.22M (13) scheduled
−$20.22M
31,757
0.0288%
$7.71M
−51.9%
Cunningham Everett
SVP, Commercial
$12.48M (11) scheduled
−$12.48M
38,311
0.0347%
$9.30M
+12.3%
Deppe Michael J
SVP, Corp. Controller & CAO
$6.97M (10) scheduled
−$6.97M
35,196
0.0319%
$8.54M
+45.0%
STANZIONE DANIEL
Director
$6.25M (5) scheduled
−$6.25M
28,349
0.0257%
$6.88M
−14.4%
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
$5.19M (9) scheduled
−$5.19M
13,557
0.0123%
$3.29M
+59.5%
Plewman Patrick
SVP for Diagnostic Services
$4.60M (10) scheduled
−$4.60M
15,293
0.0139%
$3.71M
+64.0%
WILENSKY GAIL R
Director
$4.03M (5) scheduled
−$4.03M
20,506
0.0186%
$4.98M
+104.8%
PFEIFFER GARY M
Director
$3.90M (7) scheduled
−$3.90M
31,005
0.0281%
$7.53M
+17.1%
RING TIMOTHY M
Director
$3.00M (7) scheduled
−$3.00M
31,140
0.0282%
$7.56M
+85.1%
DELANEY MARK E
SVP & Chief Commercial Officer
$2.30M (6) scheduled
−$2.30M
10,335
0.0094%
$2.51M
+497.1%
Gregg Vicky B
Director
$762.01K (3)
−$762.01K
18,386
0.0167%
$4.46M
+137.7%
BRITELL JENNE K
Director
$635.73K (1) scheduled
−$635.73K
14,479
0.0131%
$3.51M
−27.5%
EGLINTON MANNER CARRIE
SVP, Advanced Diagnostics
$555.08K (2)
−$555.08K
48,391
0.0438%
$11.75M
+172.6%
LEIDEN JEFFREY M
Director
$346.98K (3)
−$346.98K
6,000
0.0054%
$1.46M
−0.4%
ZIEGLER JOHN B
Director
$191.02K (1)
−$191.02K
16,557
0.0150%
$4.02M
−10.8%
Klug Robert A
VP, Corporate Controller
$119.93K (1)
−$119.93K
6,261
0.0057%
$1.52M
+60.2%
SAMAD SAM
Executive Vice President & CFO
33,478
0.0303%
$8.13M
+113.6%
Mendez Manuel O.
SVP & Chief Commercial Officer
29,045
0.0263%
$7.05M
+17.3%
MAIN TIMOTHY L
Director
22,460
0.0203%
$5.45M
+176.7%
MORRISON DENISE M
Director
11,929
0.0108%
$2.90M
+3,398%
Lassiter Wright III
Director
10,323
0.0094%
$2.51M
+1,730%
Doi Tracey
Director
7,748
0.0070%
$1.88M
+2,083%
Torley Helen
Director
6,260
0.0057%
$1.52M
Diaz Luis
Director
5,196
0.0047%
$1.26M
GARDNER MARK A
SVP of Molecular Gen & Oncol
4,673
0.0042%
$1.13M
+366.4%
CARTER ROBERT B
Director
3,864
0.0035%
$937.87K
WENTWORTH TIMOTHY C
Director
1,358
0.0012%
$329.61K
+135,700%
Insider
Date
Role
Action
Shares
Price
Amount
PREVOZNIK MICHAEL E
28 Aug 2026
SVP & General Counsel
Sold after exercise
430
$244.51
$105.14K
PREVOZNIK MICHAEL E
28 Aug 2026
SVP & General Counsel
Sold after exercise
6,237
$243.63
$1.52M
PREVOZNIK MICHAEL E
28 Aug 2026
SVP & General Counsel
Sold after exercise
16,010
$242.88
$3.89M
KUPPUSAMY KARTHIK
4 Jun 2026
SVP, Clinical Solutions
Sold after exercise
8,147
$200.00
$1.63M
Doherty Catherine T.
13 Feb 2026
EVP, Regional Businesses
Sold after exercise
351
$209.10
$73.39K
Doherty Catherine T.
13 Feb 2026
EVP, Regional Businesses
Sold after exercise
1,619
$208.21
$337.09K
Doherty Catherine T.
13 Feb 2026
EVP, Regional Businesses
Sold after exercise
3,500
$207.08
$724.79K
Doherty Catherine T.
13 Feb 2026
EVP, Regional Businesses
Sold after exercise
10,122
$206.37
$2.09M
Doherty Catherine T.
13 Feb 2026
EVP, Regional Businesses
Sold after exercise
10,573
$205.21
$2.17M
Plewman Patrick
10 Feb 2026
SVP for Diagnostic Services
Sold after exercise
5,662
$204.00
$1.16M
Davis J. E.
25 Nov 2025
CEO and President
Sold after exercise
4,747
$192.97
$916.04K
Davis J. E.
25 Nov 2025
CEO and President
Sold after exercise
41,004
$192.27
$7.88M
Davis J. E.
25 Nov 2025
CEO and President
Sold after exercise
9,342
$191.59
$1.79M
DELANEY MARK E
18 Nov 2025
SVP & Chief Commercial Officer
Sold after exercise
7,946
$187.35
$1.49M
PREVOZNIK MICHAEL E
26 Sep 2025
SVP & General Counsel
Sold after exercise
144
$188.66
$27.17K
PREVOZNIK MICHAEL E
26 Sep 2025
SVP & General Counsel
Sold after exercise
83
$187.22
$15.54K
PREVOZNIK MICHAEL E
24 Sep 2025
SVP & General Counsel
Sold after exercise
175
$187.02
$32.73K
PREVOZNIK MICHAEL E
23 Sep 2025
SVP & General Counsel
Sold after exercise
28,288
$187.12
$5.29M
Plewman Patrick
19 Aug 2025
SVP for Diagnostic Services
Sold after exercise
4,532
$183.00
$829.36K
Plewman Patrick
6 Aug 2025
SVP for Diagnostic Services
Sold after exercise
1,975
$175.00
$345.63K
Plewman Patrick
6 Aug 2025
SVP for Diagnostic Services
Sold after exercise
3,560
$175.00
$623.00K
KUPPUSAMY KARTHIK
30 Jul 2025
SVP, Clinical Solutions
Sold after exercise
5,224
$167.40
$874.50K
KUPPUSAMY KARTHIK
30 Jul 2025
SVP, Clinical Solutions
Sold after exercise
3,045
$167.40
$509.73K
PREVOZNIK MICHAEL E
29 Nov 2024
SVP & General Counsel
Sold after exercise
32,137
$163.15
$5.24M
PREVOZNIK MICHAEL E
29 Nov 2024
SVP & General Counsel
Sold after exercise
3,009
$162.26
$488.24K
Doherty Catherine T.
27 Nov 2024
EVP, Regional Businesses
Sold after exercise
28,300
$163.13
$4.62M
Doherty Catherine T.
27 Nov 2024
EVP, Regional Businesses
Sold after exercise
4,803
$162.14
$778.78K
Deppe Michael J
6 Nov 2024
SVP, Corp. Controller & CAO
Sold after exercise
5,189
$154.74
$802.96K
Deppe Michael J
6 Nov 2024
SVP, Corp. Controller & CAO
Sold after exercise
2,331
$154.03
$359.05K
Deppe Michael J
6 Nov 2024
SVP, Corp. Controller & CAO
Sold after exercise
2,600
$152.71
$397.05K
Deppe Michael J
6 Nov 2024
SVP, Corp. Controller & CAO
Sold after exercise
4,135
$154.74
$639.83K
Deppe Michael J
6 Nov 2024
SVP, Corp. Controller & CAO
Sold after exercise
2,400
$153.98
$369.56K
Deppe Michael J
6 Nov 2024
SVP, Corp. Controller & CAO
Sold after exercise
2,100
$152.70
$320.68K
PREVOZNIK MICHAEL E
29 Aug 2024
SVP & General Counsel
Sold after exercise
32,551
$154.97
$5.04M
RING TIMOTHY M
1 Dec 2022
Director
Sold after exercise
2,025
$152.50
$308.81K
Doherty Catherine T.
28 Nov 2022
SVP, Regional Businesses
Sold after exercise
23,407
$149.37
$3.50M
Doherty Catherine T.
28 Nov 2022
SVP, Regional Businesses
Sold after exercise
17,358
$148.92
$2.58M
RING TIMOTHY M
1 Nov 2022
Director
Sold after exercise
2,000
$144.06
$288.12K
Deppe Michael J
26 Oct 2022
VP, Corp. Controller & CAO
Sold after exercise
15,497
$145.00
$2.25M
RING TIMOTHY M
3 Oct 2022
Director
Sold after exercise
2,000
$123.39
$246.78K
RING TIMOTHY M
1 Sep 2022
Director
Sold after exercise
2,000
$125.02
$250.04K
RING TIMOTHY M
1 Aug 2022
Director
Sold after exercise
2,000
$136.04
$272.08K
RING TIMOTHY M
1 Jul 2022
Director
Sold after exercise
2,000
$133.47
$266.94K
RUSCKOWSKI STEPHEN H
25 May 2022
Chairman, CEO and President
Sold after exercise
900
$142.13
$127.92K
RUSCKOWSKI STEPHEN H
25 May 2022
Chairman, CEO and President
Sold after exercise
4,131
$141.35
$583.91K
RUSCKOWSKI STEPHEN H
25 May 2022
Chairman, CEO and President
Sold after exercise
9,823
$140.58
$1.38M
RUSCKOWSKI STEPHEN H
25 May 2022
Chairman, CEO and President
Sold after exercise
651
$142.15
$92.54K
RUSCKOWSKI STEPHEN H
25 May 2022
Chairman, CEO and President
Sold after exercise
2,565
$141.36
$362.59K
RUSCKOWSKI STEPHEN H
25 May 2022
Chairman, CEO and President
Sold after exercise
6,821
$140.60
$959.05K
RUSCKOWSKI STEPHEN H
24 May 2022
Chairman, CEO and President
Sold after exercise
156,282
$140.12
$21.90M
RUSCKOWSKI STEPHEN H
24 May 2022
Chairman, CEO and President
Sold after exercise
126,126
$140.12
$17.67M
RUSCKOWSKI STEPHEN H
23 May 2022
Chairman, CEO and President
Sold after exercise
300
$142.24
$42.67K
RUSCKOWSKI STEPHEN H
23 May 2022
Chairman, CEO and President
Sold after exercise
1,000
$141.51
$141.51K
RUSCKOWSKI STEPHEN H
23 May 2022
Chairman, CEO and President
Sold after exercise
41,268
$140.12
$5.78M
RUSCKOWSKI STEPHEN H
23 May 2022
Chairman, CEO and President
Sold after exercise
200
$142.26
$28.45K
RUSCKOWSKI STEPHEN H
23 May 2022
Chairman, CEO and President
Sold after exercise
800
$141.54
$113.23K
RUSCKOWSKI STEPHEN H
23 May 2022
Chairman, CEO and President
Sold after exercise
33,898
$140.12
$4.75M
PREVOZNIK MICHAEL E
17 May 2022
SVP & General Counsel
Sold after exercise
50,604
$139.97
$7.08M
Doherty Catherine T.
29 Nov 2021
SVP, Group Exec. Clin. Fran.
Sold after exercise
14,575
$157.53
$2.30M
Doherty Catherine T.
29 Nov 2021
SVP, Group Exec. Clin. Fran.
Sold after exercise
15,908
$156.86
$2.50M
Doherty Catherine T.
29 Nov 2021
SVP, Group Exec. Clin. Fran.
Sold after exercise
3,532
$155.77
$550.19K
Doherty Catherine T.
29 Nov 2021
SVP, Group Exec. Clin. Fran.
Sold after exercise
3,250
$154.79
$503.07K
Doherty Catherine T.
29 Nov 2021
SVP, Group Exec. Clin. Fran.
Sold after exercise
300
$153.38
$46.01K
RUSCKOWSKI STEPHEN H
29 Jul 2021
Chairman, CEO and President
Sold after exercise
4,193
$141.22
$592.12K
RUSCKOWSKI STEPHEN H
29 Jul 2021
Chairman, CEO and President
Sold after exercise
5,300
$140.59
$745.13K
RUSCKOWSKI STEPHEN H
28 Jul 2021
Chairman, CEO and President
Sold after exercise
139,751
$140.14
$19.58M
WILENSKY GAIL R
27 Jul 2021
Director
Sold after exercise
6,111
$139.27
$851.07K
WILENSKY GAIL R
27 Jul 2021
Director
Sold after exercise
6,111
$139.32
$851.40K
RUSCKOWSKI STEPHEN H
27 Jul 2021
Chairman, CEO and President
Sold after exercise
32,788
$140.01
$4.59M
RUSCKOWSKI STEPHEN H
26 Jul 2021
Chairman, CEO and President
Sold after exercise
5,813
$140.03
$813.99K
PREVOZNIK MICHAEL E
5 May 2021
SVP & General Counsel
Sold after exercise
44,939
$137.00
$6.16M
GUINAN MARK
24 Dec 2020
Executive Vice President & CFO
Sold after exercise
22,563
$121.18
$2.73M
GUINAN MARK
24 Dec 2020
Executive Vice President & CFO
Sold after exercise
59,193
$120.06
$7.11M
WILENSKY GAIL R
24 Nov 2020
Director
Sold after exercise
6,111
$126.02
$770.12K
Deppe Michael J
21 Oct 2020
VP, Corp. Controller & CAO
Sold after exercise
4,750
$125.00
$593.75K
Deppe Michael J
21 Oct 2020
VP, Corp. Controller & CAO
Sold after exercise
5,700
$125.00
$712.50K
RUSCKOWSKI STEPHEN H
16 Oct 2020
Chairman, CEO and President
Sold after exercise
291,997
$120.00
$35.04M
PREVOZNIK MICHAEL E
14 Oct 2020
SVP & General Counsel
Sold after exercise
35,591
$119.00
$4.24M
Doherty Catherine T.
2 Sep 2020
SVP, Group Exec. Clin. Fran.
Sold after exercise
3,776
$111.13
$419.62K
Doherty Catherine T.
2 Sep 2020
SVP, Group Exec. Clin. Fran.
Sold after exercise
54,616
$110.57
$6.04M
RING TIMOTHY M
8 Jun 2020
Director
Sold after exercise
11,730
$116.60
$1.37M
GUINAN MARK
8 Jun 2020
Executive Vice President & CFO
Sold after exercise
8,524
$118.60
$1.01M
GUINAN MARK
8 Jun 2020
Executive Vice President & CFO
Sold after exercise
18,246
$117.65
$2.15M
GUINAN MARK
8 Jun 2020
Executive Vice President & CFO
Sold after exercise
45,826
$116.81
$5.35M
RUSCKOWSKI STEPHEN H
27 Apr 2020
Chairman, CEO and President
Sold after exercise
11,717
$112.01
$1.31M
RUSCKOWSKI STEPHEN H
10 Mar 2020
Chairman, CEO and President
Sold after exercise
100
$112.19
$11.22K
RUSCKOWSKI STEPHEN H
6 Mar 2020
Chairman, CEO and President
Sold after exercise
2,000
$116.27
$232.54K
RUSCKOWSKI STEPHEN H
6 Mar 2020
Chairman, CEO and President
Sold after exercise
3,937
$115.45
$454.53K
RUSCKOWSKI STEPHEN H
6 Mar 2020
Chairman, CEO and President
Sold after exercise
16,426
$114.24
$1.88M
RUSCKOWSKI STEPHEN H
6 Mar 2020
Chairman, CEO and President
Sold after exercise
36,790
$113.65
$4.18M
RUSCKOWSKI STEPHEN H
6 Mar 2020
Chairman, CEO and President
Sold after exercise
171,025
$112.21
$19.19M
Davis J. E.
2 Jan 2020
EVP, General Diagnostics
Sold after exercise
8,853
$106.51
$942.94K
Davis J. E.
2 Jan 2020
EVP, General Diagnostics
Sold after exercise
69,003
$105.45
$7.28M
Davis J. E.
2 Jan 2020
EVP, General Diagnostics
Sold after exercise
7,423
$106.51
$790.65K
Davis J. E.
2 Jan 2020
EVP, General Diagnostics
Sold after exercise
58,258
$105.46
$6.14M
PREVOZNIK MICHAEL E
27 Nov 2019
SVP & General Counsel
Sold after exercise
500
$107.83
$53.92K
PREVOZNIK MICHAEL E
27 Nov 2019
SVP & General Counsel
Sold after exercise
32,193
$107.53
$3.46M
PREVOZNIK MICHAEL E
27 Nov 2019
SVP & General Counsel
Sold after exercise
11,863
$107.15
$1.27M
WILENSKY GAIL R
26 Nov 2019
Director
Sold after exercise
8,000
$107.17
$857.35K
Deppe Michael J
17 Sep 2019
VP, Corp. Controller & CAO
Sold after exercise
5,000
$106.00
$530.00K
GUINAN MARK
13 Jun 2019
Executive Vice President & CFO
Sold after exercise
73,005
$100.00
$7.30M
RUSCKOWSKI STEPHEN H
13 Jun 2019
Chairman, President and CEO
Sold after exercise
244,565
$100.00
$24.46M
Davis J. E.
24 Apr 2019
EVP, General Diagnostics
Sold after exercise
47,574
$95.00
$4.52M
Doherty Catherine T.
4 Apr 2019
SVP, Group Exec. Clin. Fran.
Sold after exercise
5,890
$90.59
$533.59K
Doherty Catherine T.
4 Apr 2019
SVP, Group Exec. Clin. Fran.
Sold after exercise
60,492
$90.59
$5.48M
WILENSKY GAIL R
22 Feb 2019
Director
Sold after exercise
8,000
$87.78
$702.22K
Cunningham Everett
10 Jul 2018
SVP, Commercial
Sold after exercise
40,328
$112.00
$4.52M
PREVOZNIK MICHAEL E
10 Jul 2018
SVP & General Counsel
Sold after exercise
30,780
$113.07
$3.48M
Cunningham Everett
2 Jul 2018
SVP, Commercial
Sold after exercise
781
$110.12
$86.01K
Cunningham Everett
2 Jul 2018
SVP, Commercial
Sold after exercise
7,066
$109.63
$774.62K
Cunningham Everett
2 Jul 2018
SVP, Commercial
Sold after exercise
5,583
$110.07
$614.50K
Cunningham Everett
2 Jul 2018
SVP, Commercial
Sold after exercise
33,345
$109.60
$3.65M
Cunningham Everett
2 Jul 2018
SVP, Commercial
Sold after exercise
1,496
$110.12
$164.74K
Cunningham Everett
2 Jul 2018
SVP, Commercial
Sold after exercise
19,798
$109.64
$2.17M
GUINAN MARK
25 May 2018
Executive Vice President & CFO
Sold after exercise
24,960
$106.14
$2.65M
GUINAN MARK
25 May 2018
Executive Vice President & CFO
Sold after exercise
36,573
$105.42
$3.86M
RUSCKOWSKI STEPHEN H
25 May 2018
Chairman, President and CEO
Sold after exercise
168,490
$107.00
$18.03M
Cohen Jon R
8 Mar 2018
SVP & Group Exec. Diag. Sol.
Sold after exercise
7,773
$104.77
$814.38K
Cohen Jon R
8 Mar 2018
SVP & Group Exec. Diag. Sol.
Sold after exercise
2,800
$104.77
$293.36K
Cohen Jon R
8 Mar 2018
SVP & Group Exec. Diag. Sol.
Sold after exercise
34,168
$104.09
$3.56M
Cohen Jon R
8 Mar 2018
SVP & Group Exec. Diag. Sol.
Sold after exercise
1,300
$104.77
$136.20K
Cohen Jon R
8 Mar 2018
SVP & Group Exec. Diag. Sol.
Sold after exercise
18,164
$104.09
$1.89M
Cohen Jon R
8 Mar 2018
SVP & Group Exec. Diag. Sol.
Sold after exercise
1,427
$104.76
$149.49K
Cohen Jon R
8 Mar 2018
SVP & Group Exec. Diag. Sol.
Sold after exercise
18,037
$104.09
$1.88M
RUSCKOWSKI STEPHEN H
29 Jan 2018
Chairman, President and CEO
Sold after exercise
106,840
$107.00
$11.43M
Doherty Catherine T.
24 Jan 2018
SVP, Group Exec. Clin. Fran.
Sold after exercise
21,294
$104.00
$2.21M
Davis J. E.
2 Jan 2018
EVP, General Diagnostics
Sold after exercise
63,880
$98.68
$6.30M
RUSCKOWSKI STEPHEN H
12 Sep 2017
Chairman, President and CEO
Sold after exercise
5,302
$108.12
$573.24K
RUSCKOWSKI STEPHEN H
11 Sep 2017
Chairman, President and CEO
Sold after exercise
53,933
$108.16
$5.83M
STANZIONE DANIEL
11 Sep 2017
Director
Sold after exercise
40,900
$108.07
$4.42M
RUSCKOWSKI STEPHEN H
5 Sep 2017
Chairman, President and CEO
Sold after exercise
2,525
$108.03
$272.77K
STANZIONE DANIEL
5 Sep 2017
Director
Sold after exercise
3,803
$108.01
$410.76K
Showing 250 of 287 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 645
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 49
Sales straight out of an exercise 159
Sales at will 79
Transactions with no price 0
Shares from compensation/vesting 5,959,033
Sales filed before the plan box existed 69
History held since 5 Oct 2016